Finance

Lists
000597:SHE
Northeast Pharmaceutical Group Co Ltd
CNÂ¥4.34
+0.23%
(+0.010) 1D
Oct 30, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000597...
Open
CNÂ¥4.28
High
CNÂ¥4.45
Low
CNÂ¥4.27
Mkt. cap
6.19B
Avg. vol.
12.21M
Volume
9.92M
Dividend
1.27%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 23, 2026
P/E ratio
33.32
52-wk high
CNÂ¥5.93
52-wk low
CNÂ¥4.09
EPS
CNÂ¥0.13
Shares outstanding
1.43B
No. of employees
6K
Open
CNÂ¥4.28
High
CNÂ¥4.45
Low
CNÂ¥4.27
Mkt. cap
6.19B
Avg. vol.
12.21M
Volume
9.92M
Dividend
1.27%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 23, 2026
P/E ratio
33.32
52-wk high
CNÂ¥5.93
52-wk low
CNÂ¥4.09
EPS
CNÂ¥0.13
Shares outstanding
1.43B
No. of employees
6K
News stories
From web sources and news partners
About Northeast Pharmaceutical Group Co Ltd
CEO-
Employees5.73K
Founded1946
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.60B
2.01B
1.33B
1.52B
Cost of goods sold
1.09B
1.44B
898.91M
956.35M
Cost of revenue
1.09B
1.44B
898.91M
956.35M
Research and development expenses
68.30M
34.05M
33.82M
26.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
459.82M
415.94M
381.40M
395.01M
Operating expense
614.84M
472.18M
432.98M
403.69M
Total operating expenses
1.70B
1.91B
1.33B
1.36B
Operating income
-103.91M
98.38M
-5.11M
162.35M
Other non operating income
-899.20K
-24.34M
12.16M
-20.94M
EBT including unusual items
65.43M
28.13M
71.54M
37.48M
EBT excluding unusual items
-117.82M
77.81M
-8.15M
155.64M
Income tax expense
8.65M
11.77M
24.10M
27.97M
Effective tax rate
13.22%
41.83%
33.69%
74.63%
Other operating expenses
87.61M
19.91M
18.69M
-16.66M
Net income
87.37M
26.63M
57.23M
18.23M
Net profit margin
5.47%
1.33%
4.31%
1.20%
Earnings per share
-
-
-
-
Interest and investment income
26.26M
14.43M
21.82M
19.38M
Interest expense
-13.43M
-10.65M
-8.73M
-33.43M
Net interest expenses
12.83M
3.78M
13.09M
-14.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
23.50M
225.79M
112.55M
289.76M
Gain or loss from assets sale
-255.86K
-
-413.49K
413.49K
Upcoming events
AI content may include mistakes. Learn more
Google apps